• Mitochondrial IRF3 Impairs Mitophagy to Drive Pulmonary Fibr

  2026-05-23

  This study uncovers a novel mechanism by which activated IRF3 translocates to mitochondria, impairs mitophagy, and triggers ferroptosis in alveolar epithelial cells, thereby promoting pulmonary fibrosis. The findings provide new insight into the cGAS-STING-IRF3 axis and highlight mitochondrial IRF3 as a potential therapeutic target for fibrosis intervention.

• Chlorpromazine Hydrochloride: Next-Gen Antipsychotic Researc

  2026-05-22

  Chlorpromazine hydrochloride from APExBIO empowers researchers to model dopamine receptor signaling, optimize antiemetic assays, and dissect nanoparticle-liver interactions with precision. This article delivers hands-on workflows, troubleshooting strategies, and protocol enhancements—bridging neuropharmacology and nanomedicine for advanced experimental design.

• Veratridine: A Strategic Catalyst for Precision Disease Mode

  2026-05-22

  This in-depth article explores how Veratridine, a potent voltage-gated sodium channel opener, is transforming translational research through its mechanistic precision and versatility. We connect sodium channel dynamics to chamber-specific cardiomyocyte modeling, referencing cutting-edge stem cell research and APExBIO’s validated compound reliability. Strategic guidance is provided for experimental design, protocol optimization, and cross-domain innovation in neuroscience, oncology, and cardiovascular disease platforms.

• Solving Low-Abundance Immunoblotting with ECL Chemiluminesce

  2026-05-21

  This article addresses the real-world laboratory challenges of detecting low-abundance proteins in immunoblotting workflows, focusing on the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231. Through scenario-based Q&A, it details evidence-backed strategies for achieving high sensitivity, minimizing background, and ensuring protocol reproducibility with SKU K1231. Biomedical researchers and technicians will gain actionable insights grounded in validated best practices.

• Apicidin: Selective Histone Deacetylase Inhibitor for Cancer

  2026-05-21

  Apicidin is a potent, selective histone deacetylase inhibitor with nanomolar activity against HDAC3 and HDAC6. It exhibits anti-proliferative and anti-angiogenesis effects in diverse cancer models and has emerging relevance as both a research tool and environmental mycotoxin. Its robust, well-documented benchmarks make it valuable for translational oncology and epigenetics studies.

• Paclitaxel (Taxol): Applied Workflows in Cancer Research

  2026-05-20

  Paclitaxel (Taxol) provides unmatched precision for microtubule stabilization and cell cycle arrest, enabling reproducible cancer research across diverse assay formats. This article details actionable experimental workflows, troubleshooting strategies, and emerging machine learning–driven insights that elevate Paclitaxel’s research value.

• Ibrexafungerp: Redefining Antifungal Innovation for Translat

  2026-05-20

  Explore how Ibrexafungerp (MK 3118) is transforming antifungal research and clinical paradigms. This thought-leadership article analyzes the mechanistic, translational, and experimental advantages of ibrexafungerp, focusing on its role in overcoming resistance, optimizing R&D protocols, and advancing the antifungal landscape. Grounded in the latest peer-reviewed evidence and workflow insights, it provides strategic guidance for translational researchers seeking robust solutions for candidiasis studies.

• Cisplatin (CDDP): Applied Workflows for Cancer Research Succ

  2026-05-19

  Cisplatin (CDDP) stands as a benchmark chemotherapeutic for modeling DNA damage, apoptosis, and chemotherapy resistance in both in vitro and in vivo systems. This article delivers actionable protocols, troubleshooting tactics, and innovative assay guidance, leveraging APExBIO’s Cisplatin (SKU: A8321) for reproducibility and insight in advanced cancer research.

• Silybin A: Advancing Hepatoprotective Research Beyond Standa

  2026-05-19

  Explore how Silybin A, a core silymarin compound, uniquely enables advanced liver disease and metabolic enzyme modulation research. This article unpacks mechanisms, comparative insights, and protocol innovations for scientists seeking greater precision and reproducibility.

• Tropisetron Hydrochloride in Neuroscience: Protocols & Pitfa

  2026-05-18

  Tropisetron Hydrochloride stands out as a highly selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, enabling precise interrogation of serotonin and nicotinic signaling in advanced neuropharmacology and transporter biology. This article delivers actionable workflows, troubleshooting insights, and comparative analysis to empower researchers targeting serotonin receptor signaling and renal transporter interactions.

• JAK Inhibitors Block Sensory Neuron Activation in RA Synovia

  2026-05-18

  This study demonstrates that JAK inhibitors, particularly tofacitinib, can directly block sensory neuron activation induced by rheumatoid arthritis (RA) synovial fluid. By integrating RNA sequencing, cytokine profiling, and functional assays on human iPSC-derived sensory neurons, the authors provide mechanistic evidence for the superior analgesic properties of JAK inhibitors in RA pain management.

• ALT Cancer Cells and ATR Inhibition: No Universal Hypersensi

  2026-05-17

  This study rigorously tests whether cancer cells utilizing the alternative lengthening of telomeres (ALT) pathway are intrinsically hypersensitive to ATR inhibition. Contrary to earlier reports, the authors find no general hypersensitivity, suggesting that sensitivity to ATR inhibitors is not universally linked to ALT status. These findings refine therapeutic targeting strategies in oncology.

• Clozapine N-oxide: Precision Control for Neuronal Activity M

  2026-05-16

  Clozapine N-oxide (CNO) is the gold standard chemogenetic actuator for selective neuronal activity modulation, enabling high-fidelity DREADD studies and GPCR signaling research. This article details practical workflows, protocol optimizations, and troubleshooting strategies to maximize reproducibility and data quality with CNO.

• Beyond Yield: Systems-Level Insight with HyperScribe T7 Cy3

  2026-05-15

  Explore how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit enables advanced, reproducible fluorescent RNA probe synthesis for precise in situ hybridization and molecular pathway analysis. This article uniquely bridges molecular technique with functional genomics and translational relevance.

• Bufalin-CRISPR Nanomedicine Induces Pyroptosis and Immune Re

  2026-05-15

  This study pioneers a calcium lactate nanoparticle system delivering both bufalin and CRISPR/Cas9 RNP targeting CD47 to colorectal cancer cells. By inducing pyroptosis and shifting macrophage polarization, the approach synergistically enhances antitumor immunity, offering a promising strategy to overcome immunotherapy resistance.

475 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page